Should You Sell Your Stake in Nu Skin Enterprises (NUS)?

2 weeks ago 11

Soumya Eswaran

Mon, February 16, 2026 astatine 8:23 AM CST 2 min read

Aristotle Capital Boston, LLC, an concern advisor, released its fourth-quarter capitalist missive for “Small Cap Equity Fund”. A transcript of the missive tin beryllium downloaded here. U.S. small-cap equities reported humble gains successful the 4th fourth of 2025. The 4th started arsenic a continuation of the post-Liberation Day risk-on marketplace environment, portion it ended connected a beardown note, driven by a affirmative macroeconomic backdrop. Attractive valuations, net recovery, broadening of the market, and a displacement from mega-cap stocks supported tiny caps successful the quarter. The Aristotle Small Cap Equity Fund (Class I-2) returned 1.96% successful Q4 2025, trailing the 2.19% full instrumentality of the Russell 2000 Index. Security enactment supported wide performance, portion allocation effects detracted from performance. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, Aristotle Small Cap Equity Fund featured stocks similar Nu Skin Enterprises, Inc. (NYSE:NUS). Headquartered successful Provo, Utah, Nu Skin Enterprises, Inc. (NYSE:NUS) is simply a wellness and quality attraction company. On February 13, 2026, Nu Skin Enterprises, Inc. (NYSE:NUS) banal closed astatine $8.36 per share. One-month instrumentality of Nu Skin Enterprises, Inc. (NYSE:NUS) was -27.56%, and its shares are up 10.58% implicit the past 12 months. Nu Skin Enterprises, Inc. (NYSE:NUS) has a marketplace capitalization of $407.55 million.

Aristotle Small Cap Equity Fund stated the pursuing regarding Nu Skin Enterprises, Inc. (NYSE:NUS) successful its 4th fourth 2025 capitalist letter:

"Nu Skin Enterprises, Inc. (NYSE:NUS) is simply a developer and distributor of quality and wellness solutions. The presumption was liquidated owed to deteriorated cardinal show and an ongoing strategical translation with an uncertain cardinal outlook."

Why Nu Skin Enterprises Inc (NUS) Is Surging In 2025?

Nu Skin Enterprises, Inc. (NYSE:NUS) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 20 hedge money portfolios held Nu Skin Enterprises, Inc. (NYSE:NUS) astatine the extremity of the 3rd quarter, the aforesaid arsenic successful the erstwhile quarter. While we admit the imaginable of Nu Skin Enterprises, Inc. (NYSE:NUS) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In addition, delight cheque retired our hedge money capitalist letters Q4 2025 page for much capitalist letters from hedge funds and different starring investors.

Read Entire Article